scispace - formally typeset
Open AccessJournal ArticleDOI

Mechanisms for Increased Glycolysis in the Hypertrophied Rat Heart

TLDR
It is shown that increased glucose entry and activation of the rate-limiting enzyme PFK both contribute to increased flux through the glycolytic pathway in hypertrophied hearts, and these changes can be explained by increased intracellular free [ADP] and [AMP], due to decreased energy reserve in LVH, activating the AMP-activated protein kinase cascade.
Abstract
Glycolysis increases in hypertrophied hearts but the mechanisms are unknown. We studied the regulation of glycolysis in hearts with pressure-overload LV hypertrophy (LVH), a model that showed marked increases in the rates of glycolysis (by 2-fold) and insulin-independent glucose uptake (by 3-fold). Although the V max of the key glycolytic enzymes was unchanged in this model, concentrations of free ADP, free AMP, inorganic phosphate (P i ), and fructose-2,6-bisphosphate (F-2,6-P 2 ), all activators of the rate-limiting enzyme phosphofructokinase (PFK), were increased (up to 10-fold). Concentrations of the inhibitors of PFK, ATP, citrate, and H + were unaltered in LVH. Thus, our findings show that increased glucose entry and activation of the rate-limiting enzyme PFK both contribute to increased flux through the glycolytic pathway in hypertrophied hearts. Moreover, our results also suggest that these changes can be explained by increased intracellular free [ADP] and [AMP], due to decreased energy reserve in LVH, activating the AMP-activated protein kinase cascade. This, in turn, results in enhanced synthesis of F-2,6-P 2 and increased sarcolemma localization of glucose transporters, leading to coordinated increases in glucose transport and activation of PFK.

read more

Citations
More filters
Journal ArticleDOI

The failing heart--an engine out of fuel.

TL;DR: This review describes cardiac energy metabolism, appraises the methods used for its assessment, evaluates the role of impaired energy metabolism in heart failure, and gives options for metabolic therapy.
Journal ArticleDOI

Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes

TL;DR: An overview of the cardiac metabolic network is provided and alterations observed in cardiac pathologies as well as strategies used as metabolic therapies in heart failure are highlighted.
Journal ArticleDOI

Basic Science of Pulmonary Arterial Hypertension for Clinicians New Concepts and Experimental Therapies

TL;DR: Although increased afterload initiates RV failure, which is the major cause of death/dysfunction in PAH, the RV may be amenable to cardiac-targeted therapies and targeted therapeutically.
Journal ArticleDOI

Energy metabolism in heart failure and remodelling

TL;DR: Myocytes of the failing heart undergo impressive metabolic remodelling under transcriptional and post-transcriptional control and contributes to impaired contractile reserve.
Journal ArticleDOI

Integration of cellular bioenergetics with mitochondrial quality control and autophagy.

TL;DR: The integration and interpretation of cellular bioenergetics in the context of mitochondrial quality control and genetics is the theme of this review.
References
More filters
Journal ArticleDOI

The AMP‐Activated Protein Kinase

TL;DR: The central hypothesis is that the AMP-activated protein kinase cascade appears to be an ancient system which evolved to protect cells against the effects of nutritional or environmental stress, and protects the cell by switching off ATP-consuming pathways and switching on alternative pathways for ATP generation.
Book ChapterDOI

Glucose-6-phosphate Dehydrogenase

TL;DR: G6P-DH is inhibited by primaquine and other 8-aminoquinolines (antimalarial drugs) in millimolar concentration, as well as by phenylhydrazine, Nevertheless, the therapeutic concentration of these substances is more than tenfold lower and therefore, they have no significant effect on the measurements.
Journal ArticleDOI

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.

TL;DR: AMPK phosphorylates and activates heart PFK-2 in vitro and in intact cells, and is likely to be involved in the stimulation of heart glycolysis during ischaemia.
Journal ArticleDOI

Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport

TL;DR: Data suggest that AICAR and contraction stimulate glucose transport by a similar insulin-independent signaling mechanism and are consistent with the hypothesis that AMPK is involved in exercise-stimulated glucose uptake.
Journal ArticleDOI

Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions.

TL;DR: The observed equilibrium constants (Kobs) of the creatine kinase, myokinase, glucose-6-phosphatase, and fructose-1,6-diph phosphatase reactions have been determined at 38 degrees C, pH 7.0, ionic strength 0.25, and varying free magnesium concentrations.
Related Papers (5)